| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.8 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |